The novel therapeutic target and inhibitory effects of PF-429242 against Zika virus infection-Reference-Cited by-同舟云学术

The novel therapeutic target and inhibitory effects of PF-429242 against Zika virus infection

Published:2021-08 Issue: Volume:192 Page:105121
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Raini Sandra Kendra,Takamatsu Yuki,Dumre Shyam Prakash^ORCID,Urata Shuzo,Mizukami Shusaku^ORCID,Moi Meng Ling,Hayasaka Daisuke,Inoue Shingo,Morita Kouichi,Ngwe Tun Mya Myat^ORCID

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference47 articles.

1. Antimalarials: molecular drug targets and mechanism of action;Achieng;Curr. Top. Med. Chem.,2017

2. Evaluation of anti-Zika virus activities of broad-spectrum antivirals and NIH clinical collection compounds using a cell-based, high-throughput screen assay;Adcock;Antivir. Res.,2017

3. Effects of sterol regulatory element-binding protein (SREBP) in chickens;Alipour;Lipids Health Dis.,2012

4. Heterogeneity in cancer cells : variation in drug response in different primary and secondary colorectal cancer cell lines in vitro;Arul;In Vitro Cell. Develop. Biol. - Animal,2017

5. Antiviral activities of selected antimalarials against dengue virus type 2 and Zika virus;Balasubramanian;Antivir. Res.,2017

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High expression of oleoyl-ACP hydrolase underpins life-threatening respiratory viral diseases;Cell;2024-08

2. Integrated re-analysis of transcriptomic and proteomic datasets reveals potential mechanisms for Zika viral-based oncolytic therapy in neuroblastoma;F1000Research;2024-05-21

3. SARS-CoV-2 nucleocapsid protein promotes TMAO-induced NLRP3 inflammasome activation by SCAP–SREBP signaling pathway;Tissue and Cell;2024-02

4. Lipid droplets in pathogen infection and host immunity;Acta Pharmacologica Sinica;2023-11-22

5. Integrated re-analysis of transcriptomic and proteomic datasets reveals potential mechanisms for Zika viral-based oncolytic therapy in neuroblastoma;F1000Research;2023-11-20